BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524768

EMMESSA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

EMMESSAR BIOTECH & NUTRITION L Share Price Update

As of the latest trading session, EMMESSAR BIOTECH & NUTRITION L share price is currently at ₹ 26.76, which is down by ₹ -0.57 from its previous closing. Today, the stock has fluctuated between ₹ 26.76 and ₹ 28.61. Over the past year, EMMESSAR BIOTECH & NUTRITION L has achieved a return of -26.85 %. In the last month alone, the return has been -5.10 %. Read More...

Investment Returns

Over 1 Month -5.10% Over 3 Months -19.35% Over 6 Months -2.91% Over 1 Year -26.85%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

EMMESSAR BIOTECH & NUTRITION L fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    13.40

  • P/E Ratio (TTM)

    34.18

  • Beta

    0.85

  • Book Value / share

    15.42

  • Return on equity

    10.65%

  • EPS (TTM)

    0.80

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.17

info icon alternate text

EMMESSAR BIOTECH & NUTRITION L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 0.09
Operating Expense 0.40
Net Profit 0.17
Net Profit Margin (%) 188.88
Earnings Per Share (EPS) 0.34
EBITDA 0.25
Effective Tax Rate (%) 26.08
Particulars MAR 2025 (Values in Cr)
Revenue 0.10
Operating Expense 0.44
Net Profit -0.07
Net Profit Margin (%) -70.00
Earnings Per Share (EPS) -0.16
EBITDA 0.28
Effective Tax Rate (%) 126.92
Particulars DEC 2024 (Values in Cr)
Revenue 0.10
Operating Expense 0.40
Net Profit 0.02
Net Profit Margin (%) 20.00
Earnings Per Share (EPS) 0.03
EBITDA 0.15
Effective Tax Rate (%) 84.61
Particulars SEP 2024 (Values in Cr)
Revenue 0.34
Operating Expense 0.44
Net Profit 0.28
Net Profit Margin (%) 82.35
Earnings Per Share (EPS) 0.56
EBITDA 0.43
Effective Tax Rate (%) 31.70
Particulars JUN 2024 (Values in Cr)
Revenue 0.08
Operating Expense 0.38
Net Profit 0.09
Net Profit Margin (%) 112.50
Earnings Per Share (EPS) 0.18
EBITDA 0.18
Effective Tax Rate (%) 43.75
Particulars MAR 2025 (Values in Cr)
Revenue 0.61
Operating Expense 1.66
Net Profit 0.32
Net Profit Margin (%) 52.45
Earnings Per Share (EPS) 0.61
EBITDA 1.06
Effective Tax Rate (%) 66.66
Particulars MAR 2024 (Values in Cr)
Revenue 0.56
Operating Expense 1.73
Net Profit 0.65
Net Profit Margin (%) 116.07
Earnings Per Share (EPS) 1.48
EBITDA 0.91
Effective Tax Rate (%) 19.75
Particulars MAR 2023 (Values in Cr)
Revenue 1.02
Operating Expense 1.80
Net Profit 0.50
Net Profit Margin (%) 49.01
Earnings Per Share (EPS) 0.99
EBITDA 1.06
Effective Tax Rate (%) 47.42
Particulars MAR 2022 (Values in Cr)
Revenue 0.36
Operating Expense 1.35
Net Profit 0.48
Net Profit Margin (%) 133.33
Earnings Per Share (EPS) 0.94
EBITDA 1.02
Effective Tax Rate (%) 49.46
Particulars MAR 2021 (Values in Cr)
Revenue 6.99
Operating Expense 6.20
Net Profit 1.45
Net Profit Margin (%) 20.74
Earnings Per Share (EPS) 2.88
EBITDA 2.31
Effective Tax Rate (%) 35.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 14.82
ROE % 10.65
ROCE % 10.31
Total Debt to Total Equity 0.01
EBITDA Margin 162.50
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.34
ROE % 7.79
ROCE % 13.37
Total Debt to Total Equity 0.01
EBITDA Margin 103.92
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.35
ROE % 8.09
ROCE % 14.16
Total Debt to Total Equity 0.00
EBITDA Margin 283.33
Particulars MAR 2021 (Values in Cr)
Book Value / Share 11.41
ROE % 27.18
ROCE % 37.07
Total Debt to Total Equity 0.00
EBITDA Margin 33.05
Particulars MAR 2020 (Values in Cr)
Book Value / Share 8.53
ROE % 19.26
ROCE % 17.11
Total Debt to Total Equity 0.01
EBITDA Margin 31.18
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 6.18
Total Assets 8.74
Total Liabilities 8.74
Total Equity 7.40
Share Outstanding 4996100
Price to Book Ratio 2.01
Return on Assets (%) 8.57
Return on Capital (%) 9.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.19
Total Assets 7.94
Total Liabilities 7.94
Total Equity 6.66
Share Outstanding 4996100
Price to Book Ratio 1.86
Return on Assets (%) 6.34
Return on Capital (%) 7.47
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.58
Total Assets 7.21
Total Liabilities 7.21
Total Equity 6.16
Share Outstanding 4996100
Price to Book Ratio 2.23
Return on Assets (%) 6.59
Return on Capital (%) 7.71
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.47
Total Assets 7.80
Total Liabilities 7.80
Total Equity 5.70
Share Outstanding 4996100
Price to Book Ratio 1.29
Return on Assets (%) 18.57
Return on Capital (%) 25.43
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.88
Total Assets 6.13
Total Liabilities 6.13
Total Equity 4.26
Share Outstanding 4996100
Price to Book Ratio 1.34
Return on Assets (%) 12.29
Return on Capital (%) 17.68
Particulars MAR 2024 (Values in Cr)
Net Income 0.81
Cash from Operations 0.62
Cash from Investing -0.64
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.62
Particulars MAR 2023 (Values in Cr)
Net Income 0.96
Cash from Operations 0.31
Cash from Investing -0.54
Cash from Financing 0.00
Net change in Cash -0.17
Free Cash Flow 0.34
Particulars MAR 2022 (Values in Cr)
Net Income 0.93
Cash from Operations 2.56
Cash from Investing -2.61
Cash from Financing 0.00
Net change in Cash -0.34
Free Cash Flow 2.86
Particulars MAR 2021 (Values in Cr)
Net Income 2.25
Cash from Operations 0.56
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.47
Free Cash Flow 0.56
Particulars MAR 2020 (Values in Cr)
Net Income 1.00
Cash from Operations 1.03
Cash from Investing -1.05
Cash from Financing 0.00
Net change in Cash -0.02
Free Cash Flow 1.03
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 6329.95 37.29 3.32 18636.48 4882.00 / 8165.25
BASF INDIA LTD 4628.70 51.42 5.51 20035.62 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 330.05 46.55 1.67 1110.74 252.40 / 656.00
DEEPAK FERTILIZERS & PETR 1406.60 18.10 2.84 17756.61 888.25 / 1776.95
DEEPAK NITRITE LTD 1788.15 40.18 4.52 24389.12 1770.00 / 3025.65
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 186.40 55.81 4.25 16.78 168.70 / 330.00
ATUL LTD 6329.95 41.90 3.36 18636.48 4882.00 / 8165.25
BASF INDIA LTD 4628.70 48.68 5.47 20035.62 4076.75 / 8748.10
ORIENTAL AROMATICS LTD 330.05 27.14 1.63 1110.74 252.40 / 656.00

EMMESSAR BIOTECH & NUTRITION L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
26.76 -2.12 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 27.20
  • 26 Days 28.70
  • 10 Days 27.50
  • 50 Days 30.00
  • 12 Days 27.60
  • 100 Days 32.00
  • 20 Days 28.20
  • 200 Days 34.20
27.16 PIVOT

First Support

26.53

First Resistance

27.98

Second Support

25.71

Second Resistance

28.61

Third Support

25.08

Third Resistance

29.43

RSI

42.66

ADX

33.51

MACD

-1.02

Williams % R

-56.50

Commodity Channel Index (CCI)

-98.29

Date

2025-09-01

Week

1516.00

Same Day

510.00

Month

1520.00

1 Year

0.85

3 Year

0.69

Over 1 Month

-5.10%

down

Over 1 Year

-26.85%

down

Over 3 Months

-19.35%

down

Over 3 Years

2.95%

down

Over 6 Months

-2.91%

down

Over 5 Years

12.16%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

EMMESSAR BIOTECH & NUTRITION L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

EMMESSAR BIOTECH & NUTRITION L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

EMMESSAR BIOTECH & NUTRITION L Share Price

Emmessar Biotech & Nutrition Limited, originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals. The Company has so far, succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996. To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential.

On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

ECIL's research team established that the specialty chemicals made by them had potential as 'Vital Micro Nutrients', used worldwide in research as 'tools' of Biotechnology. The Company's management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturer's and consumer's minds.

EBNL's R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well established and reputed in the USA.

EBNL's range of products has covered different aspects and unmet needs of Healthcare, which cater to and address obstinate skin problems, muscle problems, bone problems and other debilitating chronic physical ailments. Apart from this, the intellectual exchange of concepts and technology between Company, and Vibrant Life, led to path-breaking discoveries (VedaCeuticals) through a combination of core fundamentals of Nutraceuticals, Cosmeceuticals, Ayurveda, Biotechnology and Nanotechnology - giving them a new dimension to future products emerging from the stable.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Emmessar Biotech & Nutrition Ltd?

Answer Field

Emmessar Biotech & Nutrition Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 26.76 as on Sep 02 2025 02:42 PM.

What is the Market Cap of Emmessar Biotech & Nutrition Ltd Share?

Answer Field

The market cap of Emmessar Biotech & Nutrition Ltd for NSE ₹ 0.00 & for BSE ₹ 13.40 as on Sep 02 2025 02:42 PM.

What is the 52 Week High and Low of Emmessar Biotech & Nutrition Ltd?

Answer Field

The 52 Week High and Low of Emmessar Biotech & Nutrition Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 64.00 and ₹ 25.80.

What is 1 year return for Emmessar Biotech & Nutrition Ltd?

Answer Field

The 1 year returns on the stock has been -26.85%.

What is the P/E Ratio of Emmessar Biotech & Nutrition Ltd Share?

Answer Field

As on Sep 02 2025 02:42 PM the price-to-earnings (PE) ratio for Emmessar Biotech & Nutrition Ltd share is 34.18.

What is the PB ratio of Emmessar Biotech & Nutrition Ltd Share?

Answer Field

As on Sep 02 2025 02:42 PM, the price-to-book (PB) ratio for Emmessar Biotech & Nutrition Ltd share is 15.42.

How to Buy Emmessar Biotech & Nutrition Ltd Share?

Answer Field

You can trade in Emmessar Biotech & Nutrition Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Emmessar Biotech & Nutrition Ltd Share on Bajaj Broking App?

Answer Field

To buy Emmessar Biotech & Nutrition Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Emmessar Biotech & Nutrition Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91